Log in to save to my catalogue

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2320378654

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

About this item

Full title

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

Publisher

United States: Elsevier Inc

Journal title

The American heart journal, 2020-02, Vol.220, p.51-58

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Rates and predictors of major bleeding in patients with peripheral artery disease (PAD) treated with antiplatelets have not been well studied. This post hoc analysis of EUCLID aimed to determine the incidence of major/minor bleeding, predictors of major bleeding, and risk of major adverse cardiovascular events (MACE) following major bleeding events...

Alternative Titles

Full title

Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2320378654

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2320378654

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2019.11.007

How to access this item